Nicolet Advisory Services LLC Increases Stake in HealthEquity, Inc. (NASDAQ:HQY)

Nicolet Advisory Services LLC lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 5.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,218 shares of the company’s stock after acquiring an additional 233 shares during the quarter. Nicolet Advisory Services LLC’s holdings in HealthEquity were worth $330,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Mackenzie Financial Corp grew its holdings in HealthEquity by 16.0% during the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after buying an additional 325,906 shares during the last quarter. Generate Investment Management Ltd purchased a new position in shares of HealthEquity during the 2nd quarter valued at approximately $24,184,000. Vaughan Nelson Investment Management L.P. grew its stake in HealthEquity by 36.7% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after purchasing an additional 226,563 shares in the last quarter. Thrivent Financial for Lutherans boosted its holdings in HealthEquity by 924.2% in the second quarter. Thrivent Financial for Lutherans now owns 220,220 shares of the company’s stock worth $18,983,000 after purchasing an additional 198,718 shares during the period. Finally, Overbrook Management Corp acquired a new position in HealthEquity during the 2nd quarter valued at approximately $12,284,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HealthEquity

In other news, Director Frank Corvino sold 1,247 shares of the firm’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the transaction, the director now owns 4,823 shares in the company, valued at approximately $387,093.98. This trade represents a 20.54 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the sale, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This represents a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 10,536 shares of company stock worth $884,517 over the last 90 days. 2.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on HQY. The Goldman Sachs Group began coverage on shares of HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price objective for the company. Bank of America lifted their price target on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Deutsche Bank Aktiengesellschaft upped their price objective on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. BTIG Research lifted their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Finally, JMP Securities restated a “market outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $107.23.

HealthEquity Stock Performance

Shares of HQY stock opened at $104.25 on Monday. The company has a market capitalization of $9.10 billion, a price-to-earnings ratio of 86.88, a P/E/G ratio of 1.64 and a beta of 0.52. HealthEquity, Inc. has a 1-year low of $62.10 and a 1-year high of $105.73. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock’s fifty day simple moving average is $87.74 and its 200-day simple moving average is $81.95.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. The business had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. On average, sell-side analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.